美国药品NDC(国家药品编码)与药品说明书数据库(U.S. FDA National Drug Code DataBase)
检索条件:" 注册申请号=ANDA216174"
NDC包装代码 产品NDC 产品类型 商品名 通用名 剂型 给药途径 上市日期 结束日期 市场类别 申请号 标签持有者 活性成分 规格 包装描述
31722-317-30 31722-317 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Camber Pharmaceuticals, Inc PALIPERIDONE 1.5 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-317-30)
31722-320-30 31722-320 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Camber Pharmaceuticals, Inc PALIPERIDONE 9 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-320-30)
43602-295-05 43602-295 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 3 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-05)
43602-295-07 43602-295 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 3 mg/1 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-07)
43602-295-30 43602-295 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 3 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-295-30)
31722-318-30 31722-318 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Camber Pharmaceuticals, Inc PALIPERIDONE 3 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-318-30)
43602-296-05 43602-296 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 6 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-05)
43602-296-07 43602-296 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 6 mg/1 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-07)
43602-296-30 43602-296 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 6 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-296-30)
31722-319-30 31722-319 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Camber Pharmaceuticals, Inc PALIPERIDONE 6 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (31722-319-30)
43602-294-05 43602-294 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 1.5 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-05)
43602-294-07 43602-294 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 1.5 mg/1 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-07)
43602-294-30 43602-294 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 1.5 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-294-30)
43602-297-05 43602-297 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 9 mg/1 500 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-05)
43602-297-07 43602-297 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 9 mg/1 7 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-07)
43602-297-30 43602-297 HUMAN PRESCRIPTION DRUG PALIPERIDONE paliperidone TABLET, EXTENDED RELEASE ORAL 20230823 N/A ANDA ANDA216174 Ascent Pharmaceuticals, Inc. PALIPERIDONE 9 mg/1 30 TABLET, EXTENDED RELEASE in 1 BOTTLE (43602-297-30)
商品名称,通用名称,活性成分名称,申请号搜索 高级检索
©2006-2024 Drugfuture->U.S. FDA National Drug Code DataBase